These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 4669450)

  • 1. On the prevention of secondary hyperparathyroidism in experimental chronic renal disease using "proportional reduction" of dietary phosphorus intake.
    Slatopolsky E; Caglar S; Gradowska L; Canterbury J; Reiss E; Bricker NS
    Kidney Int; 1972 Sep; 2(3):147-51. PubMed ID: 4669450
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of phosphorus restriction in the prevention of secondary hyperparathyroidism in chronic renal disease.
    Slatopolsky E; Bricker NS
    Kidney Int; 1973 Aug; 4(2):141-5. PubMed ID: 4355426
    [No Abstract]   [Full Text] [Related]  

  • 3. Disordered divalent ion metabolism in kidney disease: comments on pathogenesis and treatment.
    Kleeman CR; Better OS
    Kidney Int; 1973 Aug; 4(2):73-9. PubMed ID: 4364428
    [No Abstract]   [Full Text] [Related]  

  • 4. [Secondary hyperparathyroidism in renal insufficiency. Prevention and therapy].
    Malluche HH; Ritz E
    MMW Munch Med Wochenschr; 1976 Jan; 118(5):129-30. PubMed ID: 814442
    [No Abstract]   [Full Text] [Related]  

  • 5. Hyperparathyroidism and renal failure.
    Arnaud CD
    Kidney Int; 1973 Aug; 4(2):89-95. PubMed ID: 4598144
    [No Abstract]   [Full Text] [Related]  

  • 6. Pathogenesis of secondary hyperparathyroidism in chronic renal insufficiency.
    Portale AA; Morris RC
    Miner Electrolyte Metab; 1991; 17(4):211-20. PubMed ID: 1813783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-suppressible secondary hyperparathyroidism in chronic progressive renal disease.
    Slatopolsky E; Rutherford WE; Hoffsten PE; Elkan IO; Butcher HR; Bricker NS
    Kidney Int; 1972; 1(1):38-46. PubMed ID: 5075944
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term control of hyperparathyroidism in advanced renal failure by low-phosphorus low-protein diet supplemented with calcium (without changes in plasma calcitriol).
    Combe C; Morel D; de Précigout V; Blanchetier V; Bouchet JL; Potaux L; Fournier A; Aparicio M
    Nephron; 1995; 70(3):287-95. PubMed ID: 7477615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium and phosphorus in diet therapy of uremia.
    Schoolwerth AC; Engle JE
    J Am Diet Assoc; 1975 May; 66(5):460-4. PubMed ID: 1123506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of enhanced parathyroid hormone secretion, synthesis and hyperplasia by mild dietary phosphorus restriction in early chronic renal failure in rats: possible direct role of phosphorus.
    Yi H; Fukagawa M; Yamato H; Kumagai M; Watanabe T; Kurokawa K
    Nephron; 1995; 70(2):242-8. PubMed ID: 7566311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary hyperparathyroidism in severe chronic renal failure is corrected by very-low dietary phosphate intake and calcium carbonate supplementation.
    Barsotti G; Cupisti A; Morelli E; Meola M; Cozza V; Barsotti M; Giovannetti S
    Nephron; 1998; 79(2):137-41. PubMed ID: 9647491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium and phosphate metabolism in chronic renal failure, with particular reference to the effect of 1 alpha-hydroxyvitamin D3.
    Madsen S
    Acta Med Scand Suppl; 1980; 638():3-120. PubMed ID: 6929650
    [No Abstract]   [Full Text] [Related]  

  • 13. Genesis of hyperparathyroidism.
    Reiss E; Canterbury JM
    Am J Med; 1971 May; 50(5):679-85. PubMed ID: 4932833
    [No Abstract]   [Full Text] [Related]  

  • 14. Skeletal resistance to the calcaemic action of parathyroid hormone in uraemia: a mechanism for the hypocalcaemia and secondary hyperparathyroidism of chronic renal failure.
    Massry SG
    Clin Endocrinol (Oxf); 1976; 5 Suppl():317S-325S. PubMed ID: 1052781
    [No Abstract]   [Full Text] [Related]  

  • 15. Reversal of hyperparathyroidism in response to dietary phosphorus restriction in the uremic dog.
    Kaplan MA; Canterbury JM; Bourgoignie JJ; Veliz G; Gavellas G; Reiss E; Bricker NS
    Kidney Int; 1979 Jan; 15(1):43-8. PubMed ID: 491396
    [No Abstract]   [Full Text] [Related]  

  • 16. Sevelamer hydrochloride suppresses proliferation of parathyroid cells during the early phase of chronic renal failure in rats.
    Xiao X; Liu Y; Zhong X; Liu Y; Zhou D; Xiong X; Ran J
    Nephrology (Carlton); 2019 Jan; 24(1):127-133. PubMed ID: 29278442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent hyperparathyroidism in renal transplant patients.
    Pabico RC; Ward HN; McKenna BA; Freeman RB
    Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():68-72. PubMed ID: 226952
    [No Abstract]   [Full Text] [Related]  

  • 18. The kidney as an endocrine organ involved in calcium homeostasis.
    DeLuca HF
    Kidney Int; 1973 Aug; 4(2):80-8. PubMed ID: 4364429
    [No Abstract]   [Full Text] [Related]  

  • 19. Hyperparathyroidism and experimental chronic renal failure.
    Boquist L; Bergdahl L; Andersson L
    Urol Res; 1973 May; 1(2):43-9. PubMed ID: 4775661
    [No Abstract]   [Full Text] [Related]  

  • 20. Relationship between magnesium and secondary hyperparathyroidism during long-term hemodialysis.
    Pletka P; Bernstein DS; Hampers CL; Merrill JP; Sherwood LM
    Metabolism; 1974 Jul; 23(7):619-30. PubMed ID: 4600477
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.